Results for tag: "Trokendi"

Trokendi is a brand of antiepileptic drug used to treat seizures associated with epilepsy. It is a central nervous system (CNS) drug, meaning it works by affecting the activity of nerve cells in the brain. Trokendi is a once-daily extended-release formulation of topiramate, a drug used to treat epilepsy and migraine headaches. It is available in both immediate-release and extended-release formulations. Trokendi is approved for use in adults and children over the age of two. Trokendi is marketed by Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. Other companies in the Trokendi market include Eisai Co., Ltd., GlaxoSmithKline plc, and Sunovion Pharmaceuticals, Inc. Show Less Read more